These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23826080)
1. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma. Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080 [TBL] [Abstract][Full Text] [Related]
2. Significance of FBX8 in progression of gastric cancer. Wu P; Wang F; Wang Y; Men H; Zhu X; He G; Ma W; Xin S; Wu J; Liao W; Ding Y; He M; Liang L Exp Mol Pathol; 2015 Jun; 98(3):360-6. PubMed ID: 25801334 [TBL] [Abstract][Full Text] [Related]
3. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
5. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
6. Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. Wu J; Shen SL; Chen B; Nie J; Peng BG PLoS One; 2014; 9(4):e95849. PubMed ID: 24770339 [TBL] [Abstract][Full Text] [Related]
7. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion. Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178 [TBL] [Abstract][Full Text] [Related]
8. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986 [TBL] [Abstract][Full Text] [Related]
9. FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma. Wang FF; Zhang XJ; Yan YR; Zhu XH; Yu J; Ding Y; Hu JL; Zhou WJ; Zeng ZC; Liao WT; Ding YQ; Liang L Cancer Lett; 2017 Mar; 388():85-95. PubMed ID: 27916606 [TBL] [Abstract][Full Text] [Related]
10. EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis. Gu F; Yuan S; Liu L; Zhu P; Yang Y; Pan Z; Zhou W J Cell Mol Med; 2019 Jun; 23(6):4208-4216. PubMed ID: 30957411 [TBL] [Abstract][Full Text] [Related]
11. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway. Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618 [TBL] [Abstract][Full Text] [Related]
12. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin. Lu S; Zhou W; Wei H; He L; Li L Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083 [TBL] [Abstract][Full Text] [Related]
13. Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma. Yu Y; Sun L; Ren N; Li Y; Rong L; Zhao G Int J Clin Exp Pathol; 2014; 7(11):8071-6. PubMed ID: 25550853 [TBL] [Abstract][Full Text] [Related]
14. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830 [TBL] [Abstract][Full Text] [Related]
15. RARγ-induced E-cadherin downregulation promotes hepatocellular carcinoma invasion and metastasis. Gan WJ; Wang JR; Zhu XL; He XS; Guo PD; Zhang S; Li XM; Li JM; Wu H J Exp Clin Cancer Res; 2016 Oct; 35(1):164. PubMed ID: 27756432 [TBL] [Abstract][Full Text] [Related]
16. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells]. Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940 [TBL] [Abstract][Full Text] [Related]
17. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
18. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway. Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659 [TBL] [Abstract][Full Text] [Related]
20. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]